The Food and Drug Administration (FDA) defied the advice of its own drug safety experts to warn pregnant women about Tylenol ...

Of Harvard’s schools, HSPH has been by far the most reliant on government grants—and so was the hardest hit by the Trump ...

The outcomes of a successful pre-NDA meeting with the FDA are: As agreed with the FDA, the rolling NDA submission will commence in December 2025, targeting a complete NDA submission in early 2026 and ...

RFK Jr., now US Secretary of Health and Human Services, has become a key figure in Trump’s domestic agenda and the face of ...

If you think your pharmacist can’t offer much guidance on your prescriptions, think again. While they don’t attend medical ...

Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to ...

A petition asks the FDA to change the label to better reflect research about a possible connection between acetaminophen use ...

Last month, Trump warned of a link between autism and acetaminophen use in pregnancy, going against advice from medical ...

Stay in the loop: Find local events, road trip ideas and food news in our weekly Things to Do newsletter. You may unsubscribe ...

Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy NASHVILLE, Tenn., Oct. 20, 2025 /PRNewswire/ ...

Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy NASHVILLE, Tenn., Oct. 20, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.

Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.